Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...
-
New York, USA, March 21, 2024 (GLOBE NEWSWIRE) -- PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the...
-
WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
-
New Delhi, March 05, 2024 (GLOBE NEWSWIRE) -- Global influenza vaccine market is projected to hit the market valuation of US$ 22.71 billion by 2032 from US$ 8.78 billion in 2023 at a CAGR of 11.07%...
-
New York, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight The PD-1 and PD-L1 inhibitor...
-
New York, USA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight Nanomedicine is experiencing heightened demand,...
-
New York, USA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- HDAC Inhibitor Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
-
BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for...
-
New York, USA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- STAT Inhibitors Clinical Trial Analysis: DelveInsight Evaluates a Robust Pipeline as 22+ Influential Pharma Players to Set Foot in the Domain The...
-
New York, USA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Biopharmaceuticals Global Market is Expected to Surpass 700 Billion Mark by 2028, Assesses DelveInsight The demand for biopharmaceuticals is...